Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.
Journal Article (Letter)
A new 30-gene signature has been described that separates prostate cancers of Gleason score ≤6 from those of Gleason score ≥8. It provides independent prognostic information for prostate cancers of intermediate risk (Gleason score of 7), which has the potential to stratify these patients into different risk groups. Clin Cancer Res; 23(1); 6-8. ©2016 AACRSee related article by Sinnott et al., p. 81.
Full Text
- Published version (via Digital Object Identifier)
- Pubmed Central version
- Open Access Copy from Duke
- Link to Item
Duke Authors
Cited Authors
- Yin, Y; Zhang, Q; Zhang, H; He, Y; Huang, J
Published Date
- January 1, 2017
Published In
Volume / Issue
- 23 / 1
Start / End Page
- 6 - 8
PubMed ID
- 27803045
Pubmed Central ID
- 27803045
Electronic International Standard Serial Number (EISSN)
- 1557-3265
Digital Object Identifier (DOI)
- 10.1158/1078-0432.CCR-16-2400
Language
- eng
Conference Location
- United States